Biocompatibility Pathways: Biomaterials-Induced Sterile Inflammation, Mechanotransduction, and Principles of...

Area of Science:

• Biomaterials Science
• Immunology
• Cell Biology

Background:

• Biocompatibility has been observed for decades but lacks a clear mechanistic understanding.
• Biomaterials are increasingly used in critical applications like tissue engineering and drug delivery.
• Existing models often overemphasize interfacial interactions, such as protein adsorption.

Purpose of the Study:

• To re-evaluate the primary mechanisms governing biomaterial biocompatibility.
• To identify key molecular pathways controlling host responses to biomaterials.
• To establish a framework for improving clinical outcomes through targeted interventions.

Main Methods:

• Analysis of clinical outcomes data related to biomaterial exposure.
• Detailed examination of mechanotransduction and sterile inflammation pathways.
• Investigation of damage-associated molecular patterns and inflammasome activation.
• Assessment of the role of interfacial interactions and protein adsorption.

Main Results:

• Mechanotransduction and sterile inflammation are the dominant mechanisms, not interfacial interactions.
• Sterile inflammation involves damage-associated molecular patterns and inflammasome activation.
• These pathways explain diverse clinical challenges, from nanoparticle translocation to restenosis.
• Interfacial interactions are less critical unless involved in extracellular matrix development.

Conclusions:

• A new framework for biocompatibility emphasizes mechanotransduction and sterile inflammation.
• This understanding allows for the integration of innate and adaptive immunity concepts.
• Targeting specific pathways, like NLRP3 inflammasome activation, can control host responses.
• This approach promises improved translation of biomaterial research into clinical practice.